NASDAQ:EVFM - Evofem Biosciences News Headlines

Sign in or create an account to add this stock to your watchlist.
$5.41 +0.20 (+3.84 %)
(As of 05/24/2019 04:00 PM ET)
Previous Close$5.21
Today's Range$5.22 - $5.68
52-Week Range$1.79 - $7.24
Volume61,652 shs
Average Volume54,145 shs
Market Capitalization$191.34 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58

Headlines

Evofem Biosciences (NASDAQ EVFM) News Headlines

Source:
DateHeadline
Evofem Biosciences Inc (EVFM) Receives Average Recommendation of "Buy" from BrokeragesEvofem Biosciences Inc (EVFM) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - May 18 at 2:48 AM
Evofem Biosciences, Inc. (EVFM)Evofem Biosciences, Inc. (EVFM)
finance.yahoo.com - May 14 at 10:46 AM
Evofem Biosciences to Present at 2019 RBC Capital Markets Global Healthcare ConferenceEvofem Biosciences to Present at 2019 RBC Capital Markets Global Healthcare Conference
finance.yahoo.com - May 14 at 10:46 AM
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2019 Results - Earnings Call TranscriptEvofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q1 2019 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 10:10 AM
Evofem Biosciences IncEvofem Biosciences Inc
www.bloomberg.com - May 9 at 10:20 AM
Evofem Biosciences (EVFM) Issues  Earnings Results, Misses Expectations By $0.05 EPSEvofem Biosciences (EVFM) Issues Earnings Results, Misses Expectations By $0.05 EPS
www.americanbankingnews.com - May 8 at 11:12 PM
Evofem Biosciences misses by $0.25Evofem Biosciences misses by $0.25
seekingalpha.com - May 7 at 10:18 AM
 Analysts Anticipate Evofem Biosciences Inc (EVFM) to Post -$0.45 EPS Analysts Anticipate Evofem Biosciences Inc (EVFM) to Post -$0.45 EPS
www.americanbankingnews.com - May 3 at 10:37 AM
Evofem Biosciences (EVFM) to Release Quarterly Earnings on TuesdayEvofem Biosciences (EVFM) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - May 1 at 11:00 AM
Evofem Biosciences to Report First Quarter 2019 Results and Provide Corporate Update on May 7, 2019Evofem Biosciences to Report First Quarter 2019 Results and Provide Corporate Update on May 7, 2019
finance.yahoo.com - April 30 at 10:10 AM
Evofem Bio completes patient enrollment in mid-stage AMPREVENCE trialEvofem Bio completes patient enrollment in mid-stage AMPREVENCE trial
seekingalpha.com - April 23 at 10:14 AM
Evofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b Sexually Transmitted Infections Trial of AmphoraEvofem Biosciences Announces Last Patient Enrolled for AMPREVENCE, the Phase 2b Sexually Transmitted Infections Trial of Amphora
finance.yahoo.com - April 23 at 10:14 AM
STOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Evofem Biosciences, Inc. – EVFMSTOCKHOLDER ALERT: Kaskela Law LLC Announces Investigation of Evofem Biosciences, Inc. – EVFM
finance.yahoo.com - April 16 at 11:46 AM
Evofem Biosciences Inc.Evofem Biosciences Inc.
www.barrons.com - April 11 at 11:53 AM
Evofem up 13% on bullish $80M capital raiseEvofem up 13% on bullish $80M capital raise
seekingalpha.com - April 11 at 11:53 AM
Evofem Biosciences raises $80m for new hormone-free contraceptiveEvofem Biosciences raises $80m for new hormone-free contraceptive
finance.yahoo.com - April 11 at 11:52 AM
Evofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharmaEvofem Biosciences Enters into Financing Agreement for up to $80 Million, Closes First Tranche of Strategic Investment from PDL BioPharma
finance.yahoo.com - April 11 at 11:52 AM
PDL BioPharma Announces Equity Investment in Evofem BiosciencesPDL BioPharma Announces Equity Investment in Evofem Biosciences
finance.yahoo.com - April 11 at 11:52 AM
Evofem Biosciences to Present at Needham Healthcare ConferenceEvofem Biosciences to Present at Needham Healthcare Conference
finance.yahoo.com - April 3 at 10:58 AM
Edited Transcript of EVFM earnings conference call or presentation 1-Mar-19 4:00pm GMTEdited Transcript of EVFM earnings conference call or presentation 1-Mar-19 4:00pm GMT
finance.yahoo.com - March 4 at 9:45 AM
Evofem Biosciences +2% on Q4 resultsEvofem Biosciences +2% on Q4 results
seekingalpha.com - March 1 at 10:54 AM
Evofem Biosciences to Report Fourth Quarter and Year-end 2018 Results and Provide Corporate Update on March 1, 2019Evofem Biosciences to Report Fourth Quarter and Year-end 2018 Results and Provide Corporate Update on March 1, 2019
finance.yahoo.com - February 19 at 10:48 AM
Evofem Biosciences, Amphora a Potential New Birth Control, Analysts Review and TargetEvofem Biosciences, Amphora a Potential New Birth Control, Analysts Review and Target
finance.yahoo.com - January 7 at 9:54 AM
Evofem Biosciences Provides Corporate Update and Announces Upcoming MilestonesEvofem Biosciences Provides Corporate Update and Announces Upcoming Milestones
finance.yahoo.com - January 3 at 10:14 AM
The Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and IncyteThe Zacks Analyst Blog Highlights: Amgen, Aduro, Vertex, Evofem and Incyte
finance.yahoo.com - December 20 at 4:18 PM
EVFM Powered Up, AXON Gets A Boost, ARVN On Watch - NasdaqEVFM Powered Up, AXON Gets A Boost, ARVN On Watch - Nasdaq
www.nasdaq.com - December 19 at 4:25 PM
22 Stocks Moving In Wednesdays Pre-Market Session - Benzinga22 Stocks Moving In Wednesday's Pre-Market Session - Benzinga
www.benzinga.com - December 19 at 4:25 PM
Evofem Shares Up as Birth Control Gel Succeeds in Phase III - NasdaqEvofem Shares Up as Birth Control Gel Succeeds in Phase III - Nasdaq
www.nasdaq.com - December 19 at 4:25 PM
Mid-Morning Market Update: Markets Open Lower; Hitachi To Acquire ABBs Power-Grid Unit - NasdaqMid-Morning Market Update: Markets Open Lower; Hitachi To Acquire ABB's Power-Grid Unit - Nasdaq
www.nasdaq.com - December 17 at 4:15 PM
Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study Evaluating Amphora for Hormone-Free Birth Control - PRNewswireEvofem Biosciences Announces Positive Top-Line Results of Phase 3 Study Evaluating Amphora for Hormone-Free Birth Control - PRNewswire
www.prnewswire.com - December 17 at 4:15 PM
4 Stocks Providing Investor Opportunity Right Now4 Stocks Providing Investor Opportunity Right Now
finance.yahoo.com - December 17 at 4:15 PM
Evofems birth control gel meets main study goal; shares riseEvofem's birth control gel meets main study goal; shares rise
www.nasdaq.com - December 17 at 10:07 AM
Evofem: Phase 3 AMPOWER Trial Meets Primary Endpoint - Quick FactsEvofem: Phase 3 AMPOWER Trial Meets Primary Endpoint - Quick Facts
www.nasdaq.com - December 17 at 10:07 AM
Evofem Vaults as AMPOWER ShinesEvofem Vaults as AMPOWER Shines
www.baystreet.ca - December 17 at 10:07 AM
Evofem up 36% premarket on positive Amphora resultsEvofem up 36% premarket on positive Amphora results
seekingalpha.com - December 17 at 10:07 AM
Evofem Biosciences Announces Positive Top-Line Results of Phase 3 Study Evaluating Amphora for Hormone-Free Birth ControlEvofem Biosciences Announces Positive Top-Line Results of Phase 3 Study Evaluating Amphora for Hormone-Free Birth Control
finance.yahoo.com - December 17 at 10:07 AM
Evofems hormone-free birth control gel meets main goal in key studyEvofem's hormone-free birth control gel meets main goal in key study
finance.yahoo.com - December 17 at 10:07 AM
Evofem Biosciences (EVFM) Presents At Piper Jaffray 30th Annual Healthcare Conference - SlideshowEvofem Biosciences (EVFM) Presents At Piper Jaffray 30th Annual Healthcare Conference - Slideshow
seekingalpha.com - November 29 at 4:17 PM
Evofem Biosciences to Present at Piper Jaffray Healthcare Conference on November 27, 2018Evofem Biosciences to Present at Piper Jaffray Healthcare Conference on November 27, 2018
finance.yahoo.com - November 15 at 9:45 AM
Evofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2018 Results - Earnings Call TranscriptEvofem Biosciences, Inc. (EVFM) CEO Saundra Pelletier on Q3 2018 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 9:57 AM
Edited Transcript of EVFM earnings conference call or presentation 7-Nov-18 4:00pm GMTEdited Transcript of EVFM earnings conference call or presentation 7-Nov-18 4:00pm GMT
finance.yahoo.com - November 10 at 9:57 AM
Evofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of PregnancyEvofem Biosciences Completes Phase 3 Clinical Trial of Amphora for Prevention of Pregnancy
finance.yahoo.com - November 8 at 9:59 AM
Evofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate UpdateEvofem Biosciences Reports Third Quarter 2018 Financial Results and Provides Corporate Update
finance.yahoo.com - November 7 at 10:04 AM
Evofem Biosciences to Host Key Opinion Leader Event: New Perspectives in Birth Control--Non-Hormonal, On ...Evofem Biosciences to Host Key Opinion Leader Event: New Perspectives in Birth Control--Non-Hormonal, On ...
www.prnewswire.com - November 2 at 4:00 PM
Evofem Biosciences to Host Key Opinion Leader Event: New Perspectives in Birth Control--Non-Hormonal, On Demand and Woman ControlledEvofem Biosciences to Host Key Opinion Leader Event: New Perspectives in Birth Control--Non-Hormonal, On Demand and Woman Controlled
finance.yahoo.com - November 1 at 9:38 AM
Evofem Biosciences to Report Third Quarter 2018 Results on November 7, 2018Evofem Biosciences to Report Third Quarter 2018 Results on November 7, 2018
finance.yahoo.com - October 24 at 9:59 AM
Data on Patient Acceptability and Genitourinary Effects of Evofem Biosciences Lead Product Candidate, Amphora, and its Role as a Multipurpose Vaginal pH Regulator Presented at 2018 American Society of Reproductive Medicine Annual CongressData on Patient Acceptability and Genitourinary Effects of Evofem Biosciences' Lead Product Candidate, Amphora, and its Role as a Multipurpose Vaginal pH Regulator Presented at 2018 American Society of Reproductive Medicine Annual Congress
finance.yahoo.com - October 9 at 3:56 PM
Evofem Biosciences to Present Data on Methodology and Current Status of Two Ongoing Clinical Studies of Amphora ...Evofem Biosciences to Present Data on Methodology and Current Status of Two Ongoing Clinical Studies of Amphora ...
www.prnewswire.com - October 4 at 3:57 PM
Evofem Biosciences (EVFM) to Present Data on Methodology and Current Status of Two Ongoing Clinical Studies of Amphora at FIGOEvofem Biosciences (EVFM) to Present Data on Methodology and Current Status of Two Ongoing Clinical Studies of Amphora at FIGO
www.streetinsider.com - October 3 at 9:43 AM
Benzingas Top Upgrades, Downgrades For September 26, 2018Benzinga's Top Upgrades, Downgrades For September 26, 2018
www.benzinga.com - September 27 at 9:51 AM
This page was last updated on 5/24/2019 by MarketBeat.com Staff

Featured Article: What is the Coverage Ratio?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel